OpenLegislation

Regulation 213A Insertion of new regulation 284A (Medicines with differing classification status in Great Britain and Northern Ireland)F1I1

After regulation 284, insert—

“Medicines with differing classification status in Great Britain and Northern Ireland

284A.

In the case of a medicinal product for sale or supply in Great Britain where the product concerned is not a prescription only medicine in Great Britain but is either—

(a)

a prescription only medicine in Northern Ireland; or

(b)

not authorised for sale or supply in Northern Ireland,

any advertisement to the public must include a statement that the medicinal product is not available without a prescription, or is not available for sale or supply, in Northern Ireland (as the case may be).”.

Annotations

Textual amendments

F1

Reg. 213A inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 170

Commencement

I1

Reg. 213A in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1